Novartis Ag (NVS) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$11.6 billion.
- Novartis Ag's Enterprise Value rose 1369.55% to -$11.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$11.6 billion, marking a year-over-year increase of 1369.55%. This contributed to the annual value of -$11.6 billion for FY2025, which is 1369.55% up from last year.
- As of Q4 2025, Novartis Ag's Enterprise Value stood at -$11.6 billion, which was up 1369.55% from -$9.6 billion recorded in Q3 2025.
- In the past 5 years, Novartis Ag's Enterprise Value ranged from a high of -$5.0 billion in Q1 2022 and a low of -$6000.3 billion during Q1 2021
- In the last 5 years, Novartis Ag's Enterprise Value had a median value of -$11.4 billion in 2023 and averaged -$311.8 billion.
- Its Enterprise Value has fluctuated over the past 5 years, first crashed by 115158445.3% in 2021, then skyrocketed by 9991.61% in 2022.
- Quarter analysis of 5 years shows Novartis Ag's Enterprise Value stood at -$28.3 billion in 2021, then soared by 33.18% to -$18.9 billion in 2022, then skyrocketed by 54.82% to -$8.6 billion in 2023, then crashed by 57.36% to -$13.5 billion in 2024, then grew by 13.7% to -$11.6 billion in 2025.
- Its Enterprise Value was -$11.6 billion in Q4 2025, compared to -$9.6 billion in Q3 2025 and -$7.0 billion in Q2 2025.